# Safety and Efficacy of a Single Subretinal Injection of JWK006 Gene Therapy in Subjects With Stargardt Disease(STGD1)

> **NCT06300476** · PHASE1,PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **West China Hospital** · enrollment: 9 (estimated)

## Conditions studied

- Stargardt Disease 1

## Interventions

- **GENETIC:** JWK006

## Key facts

- **NCT ID:** NCT06300476
- **Lead sponsor:** West China Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-11-20
- **Primary completion:** 2026-12-30
- **Final completion:** 2029-12-30
- **Target enrollment:** 9 (ESTIMATED)
- **Last updated:** 2024-03-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06300476

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06300476, "Safety and Efficacy of a Single Subretinal Injection of JWK006 Gene Therapy in Subjects With Stargardt Disease(STGD1)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06300476. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*